Filing Details
- Accession Number:
- 0000914190-11-000309
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-26 17:44:12
- Reporting Period:
- 2011-05-24
- Filing Date:
- 2011-05-26
- Accepted Time:
- 2011-05-26 16:44:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1180145 | Cardiovascular Systems Inc | CSII | Surgical & Medical Instruments & Apparatus (3841) | 411698056 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1461963 | William Scott Kraus | 1175 Seaton Ross Road Wayne PA 19087 | Vp Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-05-24 | 3,565 | $15.00 | 64,964 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $8.83 | 2016-10-02 | 25,880 | 25,880 | Direct | |
Common Stock | Stock Option (Right to Buy) | $8.83 | 2017-04-17 | 3,235 | 3,235 | Direct | |
Common Stock | Stock Option (Right to Buy) | $7.90 | 2017-08-06 | 9,705 | 9,705 | Direct | |
Common Stock | Warrant | $8.83 | 2009-02-25 | 2014-02-24 | 3,197 | 3,197 | Direct |
Common Stock | Warrant | $8.83 | 2009-02-25 | 2014-02-24 | 2,537 | 2,537 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2016-10-02 | 25,880 | 25,880 | Direct |
2017-04-17 | 3,235 | 3,235 | Direct |
2017-08-06 | 9,705 | 9,705 | Direct |
2014-02-24 | 3,197 | 3,197 | Direct |
2014-02-24 | 2,537 | 2,537 | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2010.
- Fully exercisable.